SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-030113
Filing Date
2023-03-08
Accepted
2023-03-08 16:16:11
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm238714d1_10ka.htm   iXBRL 10-K/A 117032
2 EXHIBIT 31.3 tm238714d1_ex31-3.htm EX-31.3 4183
3 EXHIBIT 31.4 tm238714d1_ex31-4.htm EX-31.4 4104
  Complete submission text file 0001104659-23-030113.txt   355065

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptct-20221231.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptct-20221231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptct-20221231_pre.xml EX-101.PRE 23994
8 EXTRACTED XBRL INSTANCE DOCUMENT tm238714d1_10ka_htm.xml XML 7419
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35969 | Film No.: 23716321
SIC: 2834 Pharmaceutical Preparations